REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,910,685 | +20.0% | 126,625 | +7.0% | 0.03% | +13.0% |
| Q1 2023 | $10,762,655 | +299.5% | 118,375 | +66.9% | 0.02% | +283.3% |
| Q4 2022 | $2,694,061 | +37.2% | 70,915 | -9.2% | 0.01% | +20.0% |
| Q3 2022 | $1,963,000 | +2.9% | 78,115 | +24.5% | 0.01% | 0.0% |
| Q2 2022 | $1,907,000 | +171.7% | 62,736 | +192.8% | 0.01% | +400.0% |
| Q1 2022 | $702,000 | +303.4% | 21,427 | +225.6% | 0.00% | – |
| Q4 2021 | $174,000 | -89.0% | 6,580 | -41.3% | 0.00% | -100.0% |
| Q2 2021 | $1,587,000 | +602.2% | 11,218 | +394.0% | 0.00% | – |
| Q1 2021 | $226,000 | -19.6% | 2,271 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $281,000 | -70.1% | 2,271 | -76.4% | 0.00% | -50.0% |
| Q3 2020 | $939,000 | +108.7% | 9,643 | +234.4% | 0.00% | +100.0% |
| Q2 2020 | $450,000 | +34.3% | 2,884 | +24.1% | 0.00% | 0.0% |
| Q1 2020 | $335,000 | -45.7% | 2,324 | -22.9% | 0.00% | -50.0% |
| Q4 2019 | $617,000 | – | 3,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |